¾Ë·¹¸£±â ÁÖ»çÁ¦ ½ÃÀå - ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2031³â) - Á¦Ç°º°, ¸é¿ª ¿ä¹ýº°, ÀûÀÀÁõº°, ¾Ë·¹¸£°Õº°, À¯Åë ä³Îº°, Áö¿ªº°
Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
»óǰÄÚµå : 1398829
¸®¼­Ä¡»ç : Fairfield Market Research
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 309 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 6,964,000
Unprintable PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 11,844,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®´Â Copy & Paste °¡´ÉÇÏÁö¸¸, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 10,600 £Ü 14,779,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ëÀÚ¼ö´Â 5¸í ÀÌ»óÀ̸ç Á¦ÇÑÀº ¾ø½À´Ï´Ù. Copy & Paste ¹× Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¾Ë·¹¸£±â ÁÖ»çÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â ¾à 26¾ï ´Þ·¯¿¡¼­ 2031³â ¸»¿¡´Â 62¾ï ´Þ·¯·Î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¾Ë·¹¸£±â ÁÖ»çÁ¦ ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, ±× ÁÖ¿ä ¿äÀÎÀº ¼¼°èÀûÀ¸·Î ´Ù¾çÇÑ ¾Ë·¹¸£±âÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¾Ë·¹¸£±â¼º ºñ¿°(AR), ºñ¾Ë·¹¸£±â¼º ºñ¿°(NAR), ºñƯÀÌÀû ºñ¿°ÀÇ À¯º´·ü Áß¾Ó°ªÀº °¢°¢ 29.4%, 18.1%, 12.0%·Î Áö¿ª¿¡ µû¶ó Â÷À̰¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿°ÀÇ ºóµµ Áõ°¡´Â µµ½ÃÈ­ µÈ ¹®È­ÀÇ µµÀÔ, °øÇØ, ½Ä½À°ü Àå¾Ö, ¾ËÄÚ¿Ã »ç¿ë µî°ú ÇÔ²² À½½Ä ¾Ë·¹¸£±â ¹× ÇǺΠ¾Ë·¹¸£±â¸¦ Æ÷ÇÔÇÑ ¾Ë·¹¸£±â ¹ÝÀÀÀÇ ±Þ°ÝÇÑ Áõ°¡·Î À̾îÁ³½À´Ï´Ù. ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ ÁøÈ­¿Í ÇÔ²² ¾Ë·¹¸£±â ÁÖ»ç Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Ư¼ö Ä¡·áÁ¦¿Í ÀçÁ¶ÇÕ ¸é¿ª ¿ä¹ýÀÇ ¹ßÀüÀ¸·Î ½ÃÀåÀº ²÷ÀÓ¾øÀÌ ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. °¢ Á¦Á¶¾÷ü´Â Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇÏ°í °í°´ ±â¹ÝÀ» È®´ëÇϸç Áö¸®Àû ¹üÀ§¸¦ ³ÐÈ÷±â À§ÇØ ÇÕº´, Àμö, Á¦ÈÞ ¹× ÆÄÆ®³Ê½ÊÀ» Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

¾Ë·¹¸£±â ÁÖ»çÁ¦ ½ÃÀåÀº À¯¸ÁÇÑ ¼ºÀå¼¼¿¡µµ ºÒ±¸ÇÏ°í ¿©·¯ °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¾Ë·¹¸£±â ÁÖ»çÁ¦ÀÇ Ä¡·á ±â°£ÀÌ ±æ°í, ¾Ë·¹¸£±âÀÇ ¼º°Ý°ú ´Ü°è¿¡ µû¶ó ÃÖ´ë 3-5³â Á¤µµ ¼Ò¿äµË´Ï´Ù. ȯÀÚµéÀº ³ªÀÌ, °Ç°­ »óÅÂ, À§Ä¡, °æÁ¦Àû Á¦¾àÀ¸·Î ÀÎÇØ Ä¡·á¸¦ Áß´ÜÇÏ´Â °æ¿ì°¡ ¸¹¾Æ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¾Ë·¹¸£±â ÁÖ»çÁ¦ ¹× Á¤Á¦ÀÇ ºÎÀÛ¿ëµµ ½ÃÀå Ãà¼Ò¿¡ ÇѸòÀ» Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ 10% ÀÌ»óÀÌ ºÎÀÛ¿ëÀ» °æÇèÇϰí ÀÖÀ¸¸ç, ´ëºÎºÐ ±¸°­ ¼Ò¾çÁõÀ̳ª ÀÎÈÄÅë°ú °°Àº °æÁõ¿¡¼­ ÁßÁõÀÇ ±¹¼Ò ¹ÝÀÀÀÔ´Ï´Ù.

º» º¸°í¼­´Â ¼¼°è ¾Ë·¹¸£±â ÁÖ»çÁ¦ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² Á¦Ç°º°, ¸é¿ª¿ä¹ýº°, ÀûÀÀÁõº°, ¾Ë·¹¸£°Õº°, À¯Åëä³Îº°, Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ÀÇ °æÀï µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå »ý»ê°í¿Í ¹«¿ªÅë°è, 2018³â-2023³â

Á¦4Àå °¡°Ý ºÐ¼®, 2018³â-2023³â

Á¦5Àå ¼¼°èÀÇ ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦6Àå ºÏ¹Ì ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦7Àå À¯·´ ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¾Ë·¹¸£±â¿ë ÁÖ»çÁ¦½ÃÀå Àü¸Á, 2018³â-2031³â

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Allergy Shots Market is poised for substantial growth, propelling the market valuation from approximately US$ 2.6 billion in 2024 to an estimated US$ 6.2 billion by the end of 2031.

Driving Factors

The global Allergy Shots Market is experiencing robust growth, primarily attributed to the escalating incidence of various allergy types worldwide. Allergic rhinitis (AR), non-allergic rhinitis (NAR), and nonspecific rhinitis have shown median prevalence rates of 29.4%, 18.1%, and 12.0%, respectively, with variations by region. This increasing frequency of rhinitis, combined with the adoption of urbanized cultures, pollution, poor dietary habits, and alcohol use, has led to a surge in allergic reactions, including food and skin allergies. As lifestyles evolve, the demand for allergy shots treatments is rising, driving market expansion.

Moreover, the market continually evolves with advancements in specialized therapeutics and recombinant immunotherapies. Manufacturers are embracing mergers, acquisitions, collaborations, and partnerships to broaden their product portfolios, extend their client base, and expand their geographic reach.

Challenges and Barriers

Despite its promising growth, the Allergy Shots Market faces challenges. The treatment course for Allergy Shots is lengthy, lasting up to 3 to 5 years depending on the allergy's nature and stage. Patients often discontinue treatment midway due to age, health, location, or financial constraints, hindering market expansion.

Additionally, adverse side effects associated with allergy injections and tablets have contributed to a market decline. More than 10% of patients reported experiencing adverse reactions, with the majority being mild to severe local reactions such as oral pruritus or throat discomfort.

Country-wise Insights

Competitive Landscape

The Allergy Shots Market is marked by a consolidated landscape with a small number of significant market players. Leading companies such as Aimmune Therapeutics, Hollister Allergy, Leti Pharma, and Merck KGaA are driving market growth through strategies like mergers and acquisitions, expansion, new product development, and alliances.

Key Companies Covered

Key Segments Covered in Allergy Shots Industry Research

Product:

Immunotherapy:

Indication:

Allergen:

Distribution Channel:

Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Production Output and Trade Statistics, 2018 - 2023

4. Price Analysis, 2018 - 2023

5. Global Allergy Shots Market Outlook, 2018 - 2031

6. North America Allergy Shots Market Outlook, 2018 - 2031

7. Europe Allergy Shots Market Outlook, 2018 - 2031

8. Asia Pacific Allergy Shots Market Outlook, 2018 - 2031

9. Latin America Allergy Shots Market Outlook, 2018 - 2031

10. Middle East & Africa Allergy Shots Market Outlook, 2018 - 2031

11. Competitive Landscape

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â